Abstract. Various plant species termed chloroquine (CQ) adjuvants, have been used to supplement CQ effectiveness in Madagascar. As guided by bioassay to reverse the CQ-resistant strain FCM29 of Plasmodium falciparum , two known bisbenzylisoquinoline alkaloids, three novel isoquinoline dimers and five indole alkaloids, of which three are new, were isolated from four plant species. Some structural requirements for drug resistance reversal were identified.
INTRODUCTION
Despite decades of effort aimed at the control of malaria,the disease remains a serious problem, affecting in particular the populations of developing countries, with an estimated 200-300 million cases and 2 million death reported each year (1) . The persistence of the disease in many areas and its increased incidence in others are attributable to the spread of chloroquine (CQ)-resistant strains of Plasmodium falciparum and the alarming emergence of multi-drug resistant strains of this organism. To make matters worse, only few antimalarials are available for clinical uses and the development of new ones both costly and time-comsuming. It is therefore our conviction that this disease will be with us for some time to come. Of the new strategies available for the control of malaria, reversal of drug resistance has dominated the field of malaria chemotherapy in recent years (2) . It has been shown, for example, that Ca2+ channel blockers such as verapamil, as well as several tricyclic antidepresants and various tricyclic antihistaminics are able to restore CQ sensitivity to resistant clones of P. falciparum . However, hopes for the rapid application of combination therapy with these drugs are probably premature since some such combinations increase chloroquine toxicity to host cells (3) . On the other hand, very little is known about resistance-reversing agents from plants although relevant data exists in folklore medicines. This has prompted us to evaluate the ability of some Malagasy plants to potentiate CQ action.
WORKING HYPOTHESIS
During the 1980's, malaria re-emerged in Madagascar as the most devastating of the country's tropical diseases (4) . The severity of infection is such that local populations now recognize the hitherto unknown condition to which they have given the name bemangovitra (disease of great shivering). In the course of our ethnobotanical field work, we have learned that most rural people treat malaria by means of self-medication with 1-2 tablets of CQ, (a dose thought to promote CQ resistance), together with a decoction made from various plant species, termed CQ-adjuvants (5) . We have assumed that some of these species may enhance CQ efficiency and might therefore reverse CQ resistance on the part of the malaria parasite.
RESULTS AND DISCUSSION
We have been able to demonstrate that the bisbenzylisoquinoline (BBIQ) frangchinoline 1 and its enantiomer limacine 2 respectively isolated from roots of the CQ adjuvant plants
S t r y c h n op s is thou a rs i i
Thou a r s (Menispennaceae) have significant intrinsic in vitro antimalarial effect (IC50 = 0.7 pdrnl), and also reverse in vitro CQ resistance in malaria (6) . The configuration at the C-1 and C-1' chiral carbons slightly affects the CQ enhancing activity. Compound 1 having the "S" isomeric configuration is more potent in effecting CQ resistance reversal than its enantiomer 2. Frangchinoline I and tetrandrine 3 have been investigated independently by other research group for their multi-drug resistance reversal in malaria and patented together with other derivatives including compound 2 ( (9) . As regards biological activity, compounds $,5. and 6 exhibited moderate inherent antiplasmodial activity (ICs,= 1.5 -3 pg/ml). However drug combination methods using isobolograms ( Figure 1 ) demonstrated that herveline B & C reversed in vitro CQ resistance in a dose dependent manner, whereas herveline A did not show any reversal activity (10) . Some structural requirements for CQ potentiating action in the series of isoquinoline dimers have been identified. First, it appears that the OMe group at C-12' is of paramount importance for biological activity. Moreover, there is some similarity between the hemicyclic structure of verapamil 2 and the BIQ part of isoquinoline dimers. Thus, BIQ can be considered as verapamil derivatives with less flexibility, which would result in more selectivity in biological properties. Verapamil is a calcium channel blocker whereas tetrandrine and its derivatives do not show an affinity for calcium channel blocking. We therefore believe that if any future work on the CQ resistance reserval of isoquinoline alkaloids is to have any meaning, it will be essential to associate it with the synthesis of BIQ analogues. Other compounds structurally unrelated to isoquinoline alkaloids are also needed. (Figure 2 ). Bioassay-directed fractionation led to the isolation of the two major bioactive constituents namely strychnobrasiline 3 and malagashanine 9. These two compounds were devoid of any intrinsic in vitro antiplasmodial action (IC50 = 60 ,ug/ml). However, when they were combined with CQ at a dose level much lower than required for
antimalarial effect, they markedly reversed CQ resistance. Basicity of nitrogen atoms would not be required for reversal activity in this series (11) . These findings would suggest a mechanism of action other than that of the isoquinoline alkaloids. Three new minor indole alkaloids were also isolated from S. rnyrtoides. They all reversed CQ resistance. Following toxicity studies, particularly evaluation of relaxant/convulsant effects on isolated organs, preliminary clinical trials were performed with infusions of S.
myrtoides . Results were significant (12) .
